Abstracts and Studies | ||||||||||||||||||||||||||||||||||||
National Library of
Medicine
Links to Independent Studies
Abstracts and Studies in PDF
1. Activities and characteristics of transfer
factors
Discusses the role of
TH1, TH2 and their dominate states. In addition to clinical applications.
According to William Hennen, Ph.D., Vice President
of Research and Development at 4Life, "Each and every batch of Transfer
Factor™ is tested by an independent laboratory with established,
documented credentials in assessing for transfer factor activity. Very few
laboratories have the experience or credentials to assay for TF activity.
We go to great lengths to assure the quality of transfer factor in our
product. This is the reason our distributors are consistently having such
great success with Transfer Factor™. From infants to the elderly, reports
keep coming in every day with results that have matched or exceeded our
every expectation. Transfer factor has nearly 50 years of research and
over 3,000 clinical studies and scientific papers proving its existence
and effectiveness. Our licensed patent proved for the first time that
transfer factor exists in colostrum and that it can be successfully
extracted and assayed."
This latest study reports that 4Life Transfer Factor™ and Transfer Factor Plus™ "induced immune-based killing of K562 cancer cells at a level unprecedented in our experience or known in medical research," according to the director of the laboratory. 4Life Transfer Factor™ and Transfer Factor Plus™ were tested for their ability to increase Natural Killer Cell (NK) activity by killing live cancer cells. The test results showed that 4Life Transfer Factor™ boosted NK cell activity 103% above normal immune response without supplementation, or about two times higher than the next highest product. In addition, it was revealed that Transfer Factor Plus™ increased the NK cell 248% above normal immune response without supplementation, or about five times higher than any of the other previously tested products. The best of more than 200 other products tested showed an increase of only 48.6%.
There were no difference in the responses that were related to the route of administration. We conclude that oral route of administration is efficacious and should be used when possible. We have also studied the effects of transfer factors on immune responses by recipients. The details of this research are presented in the paper by Dr. Alvarez-Thull. |